ABCA7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.744200E-01
Normal-vs-Stage2
6.017200E-01
Normal-vs-Stage3
4.160800E-01
Normal-vs-Stage4
4.339800E-01
Stage1-vs-Stage2
7.878200E-01
Stage1-vs-Stage3
1.586640E-01
Stage1-vs-Stage4
2.030200E-01
Stage2-vs-Stage3
1.267610E-01
Stage2-vs-Stage4
1.785220E-01
Stage3-vs-Stage4
7.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.950400E-01
Normal-vs-AfricanAmerican
4.377600E-01
Normal-vs-Asian
8.398600E-01
Caucasian-vs-AfricanAmerican
7.579200E-03
Caucasian-vs-Asian
1.815630E-02
AfricanAmerican-vs-Asian
6.478000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.099800E-01
Normal-vs-Female
5.855600E-01
Male-vs-Female
5.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.250000E-01
Normal-vs-Age(41-60Yrs)
5.923200E-01
Normal-vs-Age(61-80Yrs)
6.017000E-01
Normal-vs-Age(81-100Yrs)
5.969400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.861200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.556800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.727600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.452400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.634800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.845200E-01
Normal-vs-Daily Drinker
6.356600E-01
Normal-vs-Weekly Drinker
6.281200E-01
Normal-vs-Occasional Drinker
6.806800E-01
Normal-vs-Social Drinker
6.324000E-01
Non Drinker-vs-Daily Drinker
4.459600E-01
Non Drinker-vs-Weekly Drinker
7.021600E-01
Non Drinker-vs-Occasional Drinker
3.604000E-01
Non Drinker-vs-Social Drinker
5.797000E-01
Daily Drinker-vs-Weekly Drinker
9.194000E-01
Daily Drinker-vs-Occasional Drinker
6.909600E-01
Daily Drinker-vs-Social Drinker
9.570800E-01
Weekly Drinker-vs-Occasional Drinker
7.016600E-01
Weekly Drinker-vs-Social Drinker
9.673600E-01
Occasional Drinker-vs-Social Drinker
7.159800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.552600E-01
Normal-vs-Grade 2
1.597830E-01
Normal-vs-Grade 3
1.192400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.725200E-01
Grade 1-vs-Grade 3
4.974400E-01
Grade 1-vs-Grade 4
2.552600E-01
Grade 2-vs-Grade 3
8.266400E-01
Grade 2-vs-Grade 4
1.597830E-01
Grade 3-vs-Grade 4
1.192400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.053600E-01
Normal-vs-NonDiabetic
6.201600E-01
Diabetic-vs-NonDiabetic
7.668000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.741000E-01
Normal-vs-NoPancreatitis
6.054000E-01
Pancreatitis-vs-NoPancreatitis
4.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.515600E-01
Normal-vs-N1
5.721800E-01
N0-vs-N1
1.128390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.418600E-01
Normal-vs-TP53-NonMutant
5.669200E-01
TP53-Mutant-vs-TP53-NonMutant
2.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
